Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines

Chest

Volumn 143, Issue 5 SUPPL, 2013, Pages

  Detterbeck, Frank C ^a   Mazzone, Peter J ^b   Naidich, David P ^c   Bach, Peter B ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LIFE EXPECTANCY; LUNG CANCER; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SMOKING CESSATION; SPUTUM ANALYSIS; SPUTUM CYTODIAGNOSIS; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 84877623432     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2350     Document Type: Article

References (87)

1. Lewis SZ, Diekemper R, Addrizzo-Harris DJ. Methodology for development of guidelines for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5)(suppl): 41S-50S.
2. Bach P, Mirkin J, Oliver T, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012; 307 (22): 2418-2429.
3. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62 (1): 10-29.
4. Wegwarth O, Schwartz LM, Woloshin S, Gaissmaier W, Gigerenzer G. Do physicians understand cancer screening statistics? A national survey of primary care physicians in the United States. Ann Intern Med. 2012; 156 (5): 340-349.
5. Bramwell R, West H, Salmon P. Health professionals' and service users' interpretation of screening test results: experimental study. BMJ. 2006; 333 (7562): 284-286.
6. Detterbeck FC. Cancer, concepts, cohorts and complexity: avoiding oversimplification of overdiagnosis. Thorax. 2012; 67(9): 842-845.
7. Bach PB, Kelley MJ, Tate RC, McCrory DC. Screening for lung cancer: a review of the current literature. Chest. 2003; 123 (suppl 1): 72S-82S.
8. Bach PB, Niewoehner DE, Black WC; American College of Chest Physicians. Screening for lung cancer: the guidelines. Chest. 2003; 123 (suppl 1): 83S-88S.
9. Oken MM, Hocking WG, Kvale PA, et al; PLCO Project Team. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011; 306 (17): 1865-1873.
10. Hunt I, Siva M, Southon R, Treasure T. Does lung cancer screening with chest x-ray improve disease-free survival? Interact Cardiovasc Thorac Surg. 2006; 5 (4): 483-487.
11. Manser RL, Irving LB, Byrnes G, Abramson MJ, Stone CA, Campbell DA. Screening for lung cancer: a systematic review and meta-analysis of controlled trials. Thorax. 2003; 58 (9): 784-789.
12. Manser R, Irving L, Stone C, Byrnes G, Abramson M, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev. 2004; (1):CD001991.
13. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst. 2006; 98 (11): 748-756.
14. Doria-Rose VP, Marcus PM, Szabo E, Tockman MS, Melamed MR, Prorok PC. Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer. 2009; 115 (21): 5007-5017.
15. Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest. 1984; 86 (1): 44-53.
16. Tockman MS. Survival and mortality from lung cancer in a screened population: the Johns Hopkins study. Chest. 1986; 89 (suppl): 324S-325S.
17. Tockman MS, Levin ML, Frost JK, et al. Screening and detection of lung cancer. In: Aisner J, ed. Lung Cancer: Contemporary Issues in Clinical Oncology. New York, NY : Churchill-Livingstone; 1985 : 25-40.
18. Fontana RS, Sanderson DR, Woolner LB, et al. Screening for lung cancer. A critique of the Mayo Lung Project. Cancer. 1991; 67 (suppl 4): 1155-1164.
19. Kubík A, Parkin DM, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer. 1990; 45 (1): 26-33.
20. Marcus PM, Bergstralh EJ, Fagerstrom RM, et al. Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst. 2000; 92 (16): 1308-1316.
21. Friedman GD, Collen MF, Fireman BH. Multiphasic Health Checkup Evaluation: a 16-year follow-up. J Chronic Dis. 1986; 39 (6): 453-463.
22. Fontana RS. The Mayo Lung Project: a perspective. Cancer. 2000; 89 (suppl 11): 2352-2355.
23. Kubík AK, Parkin DM, Zatloukal P. Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer. 2000; 89 (suppl 11): 2363-2368.
24. Brett GZ. The value of lung cancer detection by six-monthly chest radiographs. Thorax. 1968; 23 (4): 414-420.
25. Hocking WG, Hu P, Oken MM, et al; PLCO Project Team. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst. 2010; 102 (10): 722-731.
26. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365 (5): 395-409.
27. Blanchon T, Bréchot JM, Grenier PA, et al; Dépiscan Group. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer. 2007; 58 (1): 50-58.
28. Garg K, Keith RL, Byers T, et al. Randomized controlled trial with low-dose spiral CT for lung cancer screening: feasibility study and preliminary results. Radiology. 2002; 225 (2): 506-510.
29. Gohagan JK, Marcus PM, Fagerstrom RM, et al; LUNG SCREENING STUDY RESEARCH GROUP. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. Lung Cancer. 2005; 47 (1): 9-15.
30. Infante M, Cavuto S, Lutman FR, et al; DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009; 180 (5): 445-453.
31. Lopes Pegna A, Picozzi G, Mascalchi M, et al; ITALUNG Study Research Group. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT. Lung Cancer. 2009; 64 (1): 34-40.
32. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009; 361 (23): 2221-2229.
33. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012; 67 (4): 296-301.
34. Bastarrika G, García-Velloso MJ, Lozano MD, et al. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med. 2005; 171 (12): 1378-1383.
35. Henschke CI, Naidich DP, Yankelevitz DF, et al. Early lung cancer action project: initial findings on repeat screenings. Cancer. 2001; 92 (1): 153-159.
36. Menezes RJ, Roberts HC, Paul NS, et al. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience. Lung Cancer. 2010; 67 (2): 177-183.
37. Pastorino U, Bellomi M, Landoni C, et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet. 2003; 362 (9384): 593-597.
38. Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: antilung cancer association project. J Clin Oncol. 2002; 20 (4): 911-920.
39. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005; 235 (1): 259-265.
40. Veronesi G, Bellomi M, Mulshine JL, et al. Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules. Lung Cancer. 2008; 61 (3): 340-349.
41. Wilson DO, Weissfeld JL, Fuhrman CR, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med. 2008; 178 (9): 956-961.
42. Callol L, Roig F, Cuevas A, et al. Low-dose CT: a useful and accessible tool for the early diagnosis of lung cancer in selected populations. Lung Cancer. 2007; 56 (2): 217-221.
43. Diederich S, Thomas M, Semik M, et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers. Eur Radiol. 2004; 14 (4): 691-702.
44. MacRedmond R, McVey G, Lee M, et al. Screening for lung cancer using low dose CT scanning: results of 2 year follow up. Thorax. 2006; 61 (1): 54-56.
45. Novello S, Fava C, Borasio P, et al. Three-year findings of an early lung cancer detection feasibility study with low-dose spiral computed tomography in heavy smokers. Ann Oncol. 2005; 16 (10): 1662-1666.
46. Picozzi G, Paci E, Lopez Pegna A, et al. Screening of lung cancer with low dose spiral CT: results of a three year pilot study and design of the randomised controlled trial "Italung-CT". Radiol Med (Torino). 2005; 109 (1-2): 17-26.
47. Saghir Z, Ashraf H, Dirksen A, Brodersen J, Pedersen JH. Contamination during 4 years of annual CT screening in the Danish Lung Cancer Screening Trial (DLCST). Lung Cancer. 2011; 71 (3): 323-327.
48. Aberle DR, Berg CD, Black WC, et al; National Lung Screening Trial Research Team. The National Lung Screening Trial: overview and study design. Radiology. 2011; 258 (1): 243-253.
49. Mascalchi M, Mazzoni LN, Falchini M, et al. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT. Br J Radiol. 2012; 85 (1016): 1134-1139.
50. American Association of Physicists in Medicine. AAPM Position Statement on Radiation Risks from Medical Imaging Procedures. College Park, MD : American Association of Physicists in Medicine; 2011. Policy PP25-A.
51. Charles M. UNSCEAR report 2000: sources and effects of ionizing radiation. United Nations Scientific Committee on the Effects of Atomic Radiation. J Radiol Prot. 2001; 21 (1): 83-86.
52. International Commission on Radiological Protection. Radiological protection and safety in medicine: ICRP Publication 73. Ann ICRP. 1996; 26 (2): 1-31.
53. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007; 298 (3): 317-323.
54. Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res. 2007; 168 (1): 1-64.
55. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003; 95 (6): 470-478.
56. Memorial Sloan-Kettering Cancer Center. Prediction tools. 2003. Memorial Sloan-Kettering Cancer Center website. http://www.mskcc.org/mskcc/html/12463. cfm. Accessed August 12, 2012.
57. Clarke MG, Kennedy KP, MacDonagh RP. Development of a clinical prediction model to calculate patient life expectancy: the measure of actuarial life expectancy (MALE). Med Decis Making. 2009; 29 (2): 239-246.
58. Tan A, Kuo YF, Goodwin JS. Integrating age and comorbidity to assess screening mammography utilization. Am J Prev Med. 2012; 42 (3): 229-234.
59. Wood DE, Eapen GA, Ettinger DS, et al. Lung cancer screening. J Natl Compr Canc Netw. 2012; 10 (2): 240-265.
60. Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Baseline characteristics of participants in the randomized national lung screening trial. J Natl Cancer Inst. 2010; 102 (23): 1771-1779.
61. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA. 2007; 297 (9): 953-961.
62. Wiener RS, Schwartz LM, Woloshin S, Welch HG. Populationbased risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann Intern Med. 2011; 155 (3): 137-144.
63. Infante M, Chiesa G, Solomon D, et al; DANTE Study Group. Surgical procedures in the DANTE trial, a randomized study of lung cancer early detection with spiral computed tomography: comparative analysis in the screening and control arm. J Thorac Oncol. 2011; 6 (2): 327-335.
64. Petersen RH, Hansen HJ, Dirksen A, Pedersen JH. Lung cancer screening and video-assisted thoracic surgery. J Thorac Oncol. 2012; 7 (6): 1026-1031.
65. Boffa DJ, Allen MS, Grab JD, Gaissert HA, Harpole DH, Wright CD. Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg. 2008; 135 (2): 247-254.
66. Allen MS, Darling GE, Pechet TT, et al; ACOSOG Z0030 Study Group. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg. 2006; 81 (3): 1013-1019.
67. Schipper PH, Diggs BS, Ungerleider RM, Welke KF. The influence of surgeon specialty on outcomes in general thoracic surgery: a national sample 1996 to 2005. Ann Thorac Surg. 2009; 88 (5): 1566-1572.
68. Park HS, Detterbeck FC, Boffa DJ, Kim AW. Impact of hospital volume of thoracoscopic lobectomy on primary lung cancer outcomes. Ann Thorac Surg. 2012; 93 (2): 372-379.
69. Farjah F, Flum DR, Varghese TK Jr, Symons RG, Wood DE. Surgeon specialty and long-term survival after pulmonary resection for lung cancer. Ann Thorac Surg. 2009; 87 (4): 995-1004.
70. Learn PA, Bach PB. A decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvement. Med Care. 2010; 48 (12): 1041-1049.
71. Cheng D, Downey RJ, Kernstine K, et al. Video-assisted thoracic surgery in lung cancer resection: a meta-analysis and systematic review of controlled trials. Innovations (Phila). 2007; 2 (6): 261-292.
72. Yan TD, Black D, Bannon PG, McCaughan BC. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol. 2009; 27 (15): 2553-2562.
73. Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013; 143(5)(suppl): e278S-e313S.
74. Cassidy A, Myles JP, van Tongeren M, et al. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer. 2008; 98 (2): 270-276.
75. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst. 2007; 99 (9): 715-726.
76. D'Amelio AM Jr, Cassidy A, Asomaning K, et al. Comparison of discriminatory power and accuracy of three lung cancer risk models. Br J Cancer. 2010; 103 (3): 423-429.
77. Etzel CJ, Bach PB. Estimating individual risk for lung cancer. Semin Respir Crit Care Med. 2011; 32(1):3-9.
78. Spitz MR, Etzel CJ, Dong Q, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008; 1(4): 250-254.
79. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst. 2011; 103 (13): 1058-1068.
80. Raji O, Duffy S, Olorunshola A, et al. Predictive accuracy and clinical utility of the Liverpool Lung Project Risk Model using population-based data from Europe and North America In: Proceedings from the National Cancer Research Institute; November 7-11, 2010; Liverpool, England. Abstract LB24A.
81. Silvestri GA, Nietert PJ, Zoller J, Carter C, Bradford D. Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts. Thorax. 2007; 62 (2): 126-130.
82. Patel D, Akporobaro A, Chinyanganya N, et al; Lung-SEARCH Investigators. Attitudes to participation in a lung cancer screening trial: a qualitative study. Thorax. 2012; 67 (5): 418-425.
83. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidencebased clinical practice guidelines. Chest. 2013;143(5)(suppl): e78S-e92S.
84. Wender R, Fontham ET, Barrera E Jr, et al. American Cancer Society lung cancer screening guidelines [published online ahead of print January 11, 2013]. CA Cancer J Clin. 2013. doi:10.3322/caac.21172.
85. Field JK, Smith RA, Aberle DR, et al; IASLC CT Screening Workshop 2011 Participants. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol. 2012; 7 (1): 10-19.
86. Jaklitsch MT, Jacobson FL, Austin JHM, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorax Cardiovasc Surg. 2012; 144 : 33-38.
87. Rocco G, Allen M, Altorki N, et al. Clinical statement on the role of the surgeon and surgical issues relating to CT screening programs for lung cancer: Report from The Society of Thoracic Surgeons CT Screening for Lung Cancer Task Force. Ann Thorac Surg. In press.